Bladder carcinoma
|
circTCF25
|
Up
|
Bladder carcinoma vs normal
|
Tissues (n = 40)
|
miR-103a-3p,miR-107; circTCF25-miR-103a-3p/miR-107-CDK6
|
Zhong et al. [28]
|
cSCC
|
hsa_circ_0035381
|
Up
|
cSCC vs normal
|
Tissues (n = 12)
|
hsa-miR-124-5p,hsa-miR-9-5p
|
Sand et al. [32]
|
hsa_circ_0022383
|
Down
|
hsa-miR-124-5p
|
ESCC
|
cir-ITCH
|
Down
|
ESCC vs normal
|
Tissues (n = 684)
|
miR-7, miR-17, and miR-214;Wnt/β-catenin pathway
|
Li et al. [34]
|
Gastric cancer
|
has_circ_002059
|
Down
|
Gastric cancer vs normal
|
Tissues (n = 101)
|
–
|
Li et al. [23]
|
Plasma (n = 36)
|
CRC
|
hsa_circ_001988
|
Down
|
CRC vs normal
|
Tissues (n = 31)
|
–
|
Wang et al. [24]
|
cir-ITCH
|
Down
|
CRC vs normal
|
Tissues (n = 45)
|
Wnt/β-catenin pathway
|
Huang et al. [25]
|
HCC
|
hsa_circ_0001649
|
Down
|
HCC vs normal
|
Tissues (n = 89)
|
–
|
Qin et al. [26]
|
LSCC
|
hsa_circ_104912
|
Down
|
LSCC vs normal
|
Tissues (n = 52)
|
–
|
Xuan et al. [27]
|
hsa_circ_100855
|
Up
|
APL
|
f-circRNA
|
–
|
f-circRNA-expressing vas normal
|
Cells
|
PI3K and MAPK signal transduction pathways
|
Guarnerio et al. [29]
|